Kyle C. Rouen

Kyle C. Rouen

Auto-generated profile, based on publicly available information

Kyle C. Rouen

Department of Physiology and Membrane Biology, University of California, Davis, CA, 95616, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
YHYanxiao Han
Yanxiao Han
JDJohn R. D. Dawson
John R. D. Dawson
KDKevin R. DeMarco
Kevin R. DeMarco
KRKyle C. Rouen
Kyle C. Rouen
SBSlava Bekker
Slava Bekker
IVIgor Vorobyov
Igor Vorobyov
G protein-coupled receptors (GPCRs) represent the largest group of membrane receptors for transmembrane signal transduction. Ligand-induced activation of GPCRs triggers G protein activation followed by various signaling cascades. Understanding the structural and energetic determinants of ligand binding to GPCRs and GPCRs to G proteins is crucial to the design of pharmacological treatments targeting specific conformations of these proteins to precisely control their signaling properties. In this study, we focused on interactions of a prototypical GPCR, beta-2 adrenergic receptor (β2AR), with its endogenous agonist, norepinephrine (NE), and the stimulatory G protein (Gs). Using molecular dynamics (MD) simulations, we demonstrated the stabilization of cationic NE, NE(+), binding to β2AR by Gsprotein recruitment, in line with experimental observations. We also captured the partial dissociation of the ligand from β2AR and the conformational interconversions of Gsbetween closed and open conformations in the NE(+)–β2AR–Gsternary complex while it is still bound to the receptor. The variation of NE(+) binding poses was found to alter Gsα subunit (Gsα) conformational transitions. Our simulations showed that the interdomain movement and the stacking of Gsα α1 and α5 helices are significant for increasing the distance between the Gsα and β2AR, which may indicate a partial dissociation of Gsα The distance increase commences when Gsα is predominantly in an open state and can be triggered by the intracellular loop 3 (ICL3) of β2AR interacting with Gsα, causing conformational changes of the α5 helix. Our results help explain molecular mechanisms of ligand and GPCR-mediated modulation of G protein activation.

17 September 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
RWRyan L. Woltz
Ryan L. Woltz
YZYang Zheng
Yang Zheng
WCWoori Choi
Woori Choi
KNKhoa Ngo
Khoa Ngo
PTPauline Trinh
Pauline Trinh
NCNipavan Chiamvimonvat
Nipavan Chiamvimonvat
Small-conductance Ca 2+ -activated K + channels (SK, K Ca 2) are gated solely by intracellular microdomain Ca 2+ . The channel has emerged as a therapeutic target for cardiac arrhythmias. Calmodulin (CaM) interacts with the CaM binding domain (CaMBD) of the SK channels, serving as the obligatory Ca 2+ sensor to gate the channels. In heterologous expression systems, phosphatidylinositol 4,5-bisphosphate (PIP2) coordinates with CaM in regulating SK channels. However, the roles and mechanisms of PIP2 in regulating SK channels in cardiomyocytes remain unknown. Here, optogenetics, magnetic nanoparticles, combined with Rosetta structural modeling, and molecular dynamics (MD) simulations revealed the atomistic mechanisms of how PIP2 works in concert with Ca 2+ -CaM in the SK channel activation. Our computational study affords evidence for the critical role of the amino acid residue R395 in the S6 transmembrane segment, which is localized in propinquity to the intracellular hydrophobic gate. This residue forms a salt bridge with residue E398 in the S6 transmembrane segment from the adjacent subunit. Both R395 and E398 are conserved in all known isoforms of SK channels. Our findings suggest that the binding of PIP2 to R395 residue disrupts the R395:E398 salt bridge, increasing the flexibility of the transmembrane segment S6 and the activation of the channel. Importantly, our findings serve as a platform for testing of structural-based drug designs for therapeutic inhibitors and activators of the SK channel family. The study is timely since inhibitors of SK channels are currently in clinical trials to treat atrial arrhythmias.

21 December 2023 in Journal of General Physiology
Verified
Journal Article
Open access
PDF file
KNKhoa Ngo
Khoa Ngo
DMDiego Lopez Mateos
Diego Lopez Mateos
YHYanxiao Han
Yanxiao Han
KRKyle C. Rouen
Kyle C. Rouen
SASurl-Hee Ahn
Surl-Hee Ahn
IVIgor Vorobyov
Igor Vorobyov
Human voltage-gated sodium (hNaV) channels are responsible for initiating and propagating action potentials in excitable cells, and mutations have been associated with numerous cardiac and neurological disorders. hNaV1.7 channels are expressed in peripheral neurons and are promising targets for pain therapy. The tarantula venom peptide protoxin-II (PTx2) has high selectivity for hNaV1.7 and is a valuable scaffold for designing novel therapeutics to treat pain. Here, we used computational modeling to study the molecular mechanisms of the state-dependent binding of PTx2 to hNaV1.7 voltage-sensing domains (VSDs). Using Rosetta structural modeling methods, we constructed atomistic models of the hNaV1.7 VSD II and IV in the activated and deactivated states with docked PTx2. We then performed microsecond-long all-atom molecular dynamics (MD) simulations of the systems in hydrated lipid bilayers. Our simulations revealed that PTx2 binds most favorably to the deactivated VSD II and activated VSD IV. These state-specific interactions are mediated primarily by PTx2’s residues R22, K26, K27, K28, and W30 with VSD and the surrounding membrane lipids. Our work revealed important protein–protein and protein–lipid contacts that contribute to high-affinity state-dependent toxin interaction with the channel. The workflow presented will prove useful for designing novel peptides with improved selectivity and potency for more effective and safe treatment of pain.

31 January 2025 in Molecular Pharmacology
Verified
Journal Article
Open access
JNJoshua A. Nasburg
Joshua A. Nasburg
KRKyle C. Rouen
Kyle C. Rouen
CDConnor J. Dietrich
Connor J. Dietrich
HSHeesung Shim
Heesung Shim
MZMiao Zhang
Miao Zhang
HWHeike Wulff
Heike Wulff
NS309 (6,7-dichloro-1H-indole-2,3-dione-3-oxime) is widely used as a pharmacological tool to increase the activity of small- and intermediate-conductance calcium-activated potassium channels. NS309 is assumed to function as a positive allosteric gating modulator. However, its binding site and the molecular details of its action remain unknown. Here, we show that NS309 has a profound effect on the calcium-dependent gating of the intermediate-conductance Ca2+-activated K+ channel KCa3.1. In inside-out experiments, 10 μM NS309 shifted the calcium EC50 from 430 to 31 nM. In whole-cell experiments, changing free intracellular calcium from 250 nM to 3 μM decreased the EC50 of NS309 from 74 to 8.6 nM. We further observed that NS309 could elicit greater responses than saturating calcium, making it a "superagonist." Molecular modeling suggested 2 possible binding sites for NS309 in KCa3.1, which we probed by mutagenesis and determined that NS309 is binding in the interface between the S45A segment of the intracellular S4-S5 linker and the N-lobe of the channel-associated calmodulin. Molecular dynamic simulations revealed that NS309 pushes several water molecules out of the interface pocket, establishes stable contacts with S181 and L185 in the S45A segment of KCa3.1 and E54 in calmodulin, and promotes longer sustained widening of the inner gate of KCa3.1 at V282 in the S6 segment. Polar substitutions of the hydrophobic-gating residues V282 and A279 resulted in constitutively open channels that could not be further potentiated by NS309, suggesting that NS309 produces its agonistic effects by increasing the open probability of the inner gate of KCa3.1. SIGNIFICANCE STATEMENT: The publication of the full-length cryo-electron microscopy structure of the intermediate-conductance Ca2+-activated K+ channel KCa3.1 suggested that the previously reported binding site of NS309 (6,7-dichloro-1H-indole-2,3-dione-3-oxime) was a crystallization artifact because this structure only included the C-terminus and the channel-associated calmodulin. This study demonstrates that the true binding site of NS309 is located between the S4 and S5 linker of KCa3.1 and the N-lobe of calmodulin. NS309 acts as a stabilizing force within the gating interface and increases the open probability of the inner hydrophobic gate.

28 September 2025 in bioRxiv
Verified
Preprint
Open access
KRKyle C. Rouen
Kyle C. Rouen
KNKush Narang
Kush Narang
YHYanxiao Han
Yanxiao Han
DWDavid Wang
David Wang
EJEnsley Jang
Ensley Jang
IVIgor Vorobyov
Igor Vorobyov
Unintended block of cardiac ion channels, particularly hERG (K V 11.1), remains a key concern in drug development as disruption of ion channel function can lead to deadly arrhythmia. To assess proarrhythmic risk, we investigated how drugs interact with hERG in its open and inactivated states and whether drug interactions with other cardiac channels like Na V 1.5 and Ca V 1.2 mitigate that risk. Using cryo-EM structures, we modeled open and inactivated conformations of these channels with Rosetta and AlphaFold. We then applied Site Identification by Ligand Competitive Saturation (SILCS), a physics-based pre-computed ensemble docking method, to predict drug binding affinities. SILCS leverages molecular simulation-generated free energy maps for high-throughput docking against hydrated lipid bilayer-embedded ion channel models. Bayesian machine learning was used to refine SILCS scoring using experimental IC 50 values from 69 known hERG blockers outperforming Schrödinger Glide, AutoDock Vina, and OpenEye FRED drug docking predictions. Computed drug binding affinities for hERG and Ca V 1.2 channels were used to train machine learning models that successfully classified around 300 drugs from the CredibleMeds database. Cationic nitrogen SILCS fragment free energy scores were found to be top physical properties that are predictive of drug-induced Torsades de Pointes (TdP) arrhythmia risk. This approach, which relies on the predicted binding free energies and predicted physical properties of drugs rather than the chemical structure of the drugs themselves as features could be extended to facilitate the design of new drugs where rapid assessment of arrhythmia risk can be performed prior to experimental testing.

7 April 2026 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
YTYuhua Tian
Yuhua Tian
SBSoohyeon Bae
Soohyeon Bae
XWXuesong Wu
Xuesong Wu
KRKyle C. Rouen
Kyle C. Rouen
AHAdriana Hernández-Gonzalez
Adriana Hernández-Gonzalez
JZJie Zheng
Jie Zheng
Temperature-sensitive transient receptor potential melastatin subfamily 4 (TRPM4) ion channels convert intracellular calcium increases into membrane depolarization, thereby linking these two powerful cellular signaling pathways in diverse physiological processes. TRPM4 mutations cause severe human hereditary cardiovascular and skin diseases; mysteriously, while these mutations are gain-of-function in nature, they affect the heart and the skin in a mutually exclusive manner. Here, we show that phosphatidylinositol 4,5-bisphosphate (PIP2) lipid is a required cofactor for TRPM4 activity by tightly regulating its calcium sensitivity. We detected two PIP2 binding sites and located the high-affinity site adjacent to the S4-S5 linker. We demonstrated that skin disease–associated TRPM4 mutations relieve the tight control of PIP2, resulting in elevated channel activity but only at the body surface temperature. In contrast, heart diseases are associated with mutations known to boost the number of channels, an effect we found to be annihilated by channel desensitization outside the body core. Indeed, dendritic cells from transgenic mice carrying a skin disease mutant exhibited elevated migration at 25-to-30°C range compared to those from normal mice, but no difference was observed at 37°C. These findings shed light on a molecular mechanism for dynamic regulation of cellular signaling in physiology and diseases.